Trademarkia Logo

Australia

AU$
GLYCOVERSE, GLYCOVERSE
Cancelled: Cancelled at the request of IB

Last updated on 12 Feb 2025

Owner Info

Venn Biosciences Corporation

2 Tower Place, 5th Floor, South

San Francisco CA 94080, UNITED STATES OF AMERICA

Serial Number

2300418 filed on 14 Apr 2022

Correspondent

TIMOTHY D. SITZMANN Winthrop & Weinstine, P.A.

225 South Sixth Street,

Capella Tower, Suite 3500,

UNITED STATES OF AMERICA

GLYCOVERSE, GLYCOVERSE

Classification Information


Class [041]
Educational services, namely, conducting and arranging symposia and conferences in the field of medical science, medical research, scientific research Read More

Class [042]
Providing medical and scientific research information in the field of medical science, glcyoproteomics, glycoscience, biomarkers, bioinformatics, canc Read More

Mark Details


Serial Number

2300418

Registered On

14 Apr 2022

Renewal On

NA

Mark Type

WORD, WORD

Priority Claim (Convention Details)


Date

20 Oct 2021

Mark Type

US

Legal History


Show more

Status DateAction Taken
12th Feb 2025Status change to Voided
1st Dec 2022International Registration in Australia Protected correspondence sent
30th Nov 2022IP Right Registration Published
30th Nov 2022Status change to Registered/Protected
24th Sept 2022Application Accepted correspondence sent
23rd Sept 2022IP Right has been Examined
23rd Sept 2022IP Right Acceptance Published
23rd Sept 2022Status change to Accepted
21st Sept 2022Awaiting examination
21st Sept 2022Examination expedited